Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice Post author: Post published:October 24, 2023 Post category:uncategorized This study aimed to improve the effectiveness of the rabies vaccine to help alleviate and eliminate the rabies epidemic. You Might Also Like Beta blockers linked to increased depression in heart attack patients November 11, 2024 Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge May 7, 2024 Blood-based test helps personalize breast cancer care for older patients March 19, 2026